Related Experiment Videos
Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity.
Ramu A Subbramanian1, Chikaya Moriya, Kristi L Martin
1Division of Viral Pathogenesis, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, Massachusetts 02215, USA.
Nature Biotechnology
|October 27, 2004
Summary
Tetramer technology now analyzes T-cell receptors (TCRs), enabling high-affinity TCR isolation and binding assessment. This method accurately measures peptide-MHC binding and identifies specific alleles in macaques for vaccine and immunotherapy design.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- T-cell receptors (TCRs) are crucial for adaptive immunity.
- Tetramer technology has been successfully applied to other immune molecules.
- High-affinity TCRs are essential for effective immune responses.
Purpose of the Study:
- To extend tetramer technology to T-cell receptors (TCRs).
- To isolate high-affinity TCRs with stable binding characteristics.
- To develop a method for assessing peptide-MHC binding affinity.
Main Methods:
- Tetramerization of TCR alpha beta pairs without accessory molecules.
- Flow cytometry to measure mean fluorescence intensity of tetramer-bound cells.
- Utilizing a TCR tetramer specific for the Mamu-A(*)01 allele in rhesus macaques.
Main Results:
- Successfully identified TCR alpha beta pairs and isolated high-affinity TCRs.
- Demonstrated that TCR tetramer binding accurately reflects subtle changes in cognate peptide levels.
- Accurately assessed the binding affinity of various peptides to MHC class I.
- Identified rhesus macaques expressing the Mamu-A(*)01 allele.
Conclusions:
- TCR tetramerization is a viable technology for analyzing TCRs.
- This method facilitates the assessment of the MHC-peptide interface.
- TCR tetramers can aid in the design of immunotherapeutics and vaccines.